Cite
Hefazi M, Siddiqui M, Patnaik M, et al. Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities. Leuk Res. 2015;doi: 10.1016/j.leukres.2015.09.001.
Hefazi, M., Siddiqui, M., Patnaik, M., Wolanskyj, A., Alkhateeb, H., Zblewski, D., Elliott, M., Hogan, W., Litzow, M., & Al-Kali, A. (2015). Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities. Leukemia research, . https://doi.org/10.1016/j.leukres.2015.09.001
Hefazi, Mehrdad, et al. "Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities." Leukemia research vol. (2015). doi: https://doi.org/10.1016/j.leukres.2015.09.001
Hefazi M, Siddiqui M, Patnaik M, Wolanskyj A, Alkhateeb H, Zblewski D, Elliott M, Hogan W, Litzow M, Al-Kali A. Prognostic impact of combined NPM1+/FLT3- genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities. Leuk Res. 2015 Sep 03; doi: 10.1016/j.leukres.2015.09.001. Epub 2015 Sep 03. PMID: 26410460.
Copy
Download .nbib